General Information of This Linker
Linker ID
LIN0ZSAYG
Linker Name
CN119630431A-ADC-39-LINKER
Linker Type
Cathepsin-cleavable linker
Antibody-Linker Relation
Cleavable
Structure
Formula
C31H33N3O12S2
Isosmiles
O=C(O)C[C@H](NC([C@H](NC(CCOCCOCCN1C(C(SC2=CC=CC=C2)=C(SC3=CC=CC=C3)C1=O)=O)=O)CC(O)=O)=O)C(O)=O
InChI
InChI=1S/C31H33N3O12S2/c35-23(32-21(17-24(36)37)28(40)33-22(31(43)44)18-25(38)39)11-13-45-15-16-46-14-12-34-29(41)26(47-19-7-3-1-4-8-19)27(30(34)42)48-20-9-5-2-6-10-20/h1-10,21-22H,11-18H2,(H,32,35)(H,33,40)(H,36,37)(H,38,39)(H,43,44)/t21-,22+/m1/s1
InChIKey
SIVAPZMAXJWNGM-YADHBBJMSA-N
Pharmaceutical Properties
Molecule Weight
703.748
Polar area
225.94
Complexity
1392.896425
xlogp Value
1.5783
Heavy Count
48
Rot Bonds
21
Hbond acc
11
Hbond Donor
5
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
WO2024043319A1 28 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.023 nM
Positive CEACAM6_#84.7 expression (CEACAM6_#84.7 +++/++)
Method Description
In vitro cytotoxicity of ADCs in AsPC-1 cells.
In Vitro Model Pancreatic ductal adenocarcinoma AsPC-1 cells CVCL_0152
References
Ref 1 Antibody-drug complexes